Dr. Armando Moncada
Dr. Armando Moncada is the founder of PCG Molecular, Inc., a Molecular/Genetic Information Company focused on fundamentally changing the way cancer patients are screened and treated. PCG Molecular proprietary tests generate actionable molecular/genomic information about patients’ individual cancer risk. The company’s first clinical product, MOP®, is the first commercially available comprehensive molecular information product design for use in the routine care of screening for oral (oropharyngeal) carcinoma. Aeon Global Health acquired the assets of PCG Molecular in January 2018.
Dr. Moncada’s areas of expertise include oral cancer genomics, anal cancer molecular/genomics, and GYN molecular/genomics on cogenesis. He is a member of the American Medical Association, Association for Molecular Pathology, the Society for Lower Genital Tract Disorders (ASCCP), and the American Society for Clinical Pathology (ASCP). Additionally, he is a fellow of the American Academy of Oral Medicine and a fellow and experienced inspector for the College of American Pathologists.
Dr. Moncada received his MD at the National University of Honduras, followed by postgraduate training at Tulane University School of Medicine in New Orleans. He then served as the Medical Director of Hospital Systems in Texas and New Mexico, followed by an appointment as Assistant Professor of Pathology at Baylor College of Medicine in Houston.
SHAWN K. DESAI, PH.D., J.D.
Chief Technology Officer
Shawn Desai is a licensed attorney in Georgia and also a registered patent attorney with the U.S. Patent and Trademark Office. Shawn obtained his law degree from the University of Georgia School of Law and his Ph.D. in chemistry from Emory University, where he was a George W. Woodruff Fellow. Shawn wants our clients to know that Aeon Clinical Laboratories has their best interests in mind.
Dr. Holly Carpenter, Ph.D.
Dr. Holly Carpenter, Ph.D. earned her doctoral degree in chemistry at Emory University. She was a faculty member in the department of chemistry and biochemistry at the University of North Georgia where she enjoyed teaching and conducting undergraduate research for 7 years before joining the Aeon Global Health team full-time. She enjoys working directly with physician clients and seeing patients benefit from the services Aeon provides.
James P. Canner, Ph.D., MT(AAB)
Laboratory Operations Director
JP Canner joined Aeon in June of 2016 after completing a postdoctoral research fellowship at Emory University studying the activation of skeletal muscle stem cells upon injury. He obtained his Ph.D. in Cellular, Molecular, and Developmental Biology from Tufts University Sackler School of Graduate Biomedical Sciences and his masters in Biotechnology from Boston University. JP is excited to contribute to Aeon's mission of providing Excellence in Standard of Care.
Kevin K. Desai, Ph.D.
Kevin joined Aeon after completing postdoctoral studies at the University of Wisconsin¬-Madison in the Department of Biochemistry where he received a National Institutes of Health Postdoctoral Fellowship. His postdoctoral research involved pioneering work in the area of RNA ligation and nucleic acid biochemistry. Kevin received a Ph.D. in Biochemistry from Florida State University where his research involved discovering and characterizing novel enzymes involved in metabolism, antibiotic resistance, and the detoxification of anthropogenic chemicals. Kevin is committed to applying the high scientific standards he learned in academia to his work at Aeon.